Tag: IIV4
Vaxxas’ needle-free seasonal influenza vaccine enters clinical trial
Vaxxas has commenced the Phase I clinical trial of the first needle-free inactivated seasonal influenza vaccine quadrivalent (IIV4) candidate via its proprietary high-density microarray patch (HD-MAP) technology.
Featured Article
How Taiwan is revolutionising its AI data centres with liquid cooling
The rapid advancement of artificial intelligence relies heavily on the infrastructure that supports it. As AI continues to transform industries worldwide, the demand for robust and efficient data centre operations has never been more critical. This, in turn, has brought attention to the environmental impact of these facilities.
